EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Impact of everolimus: update on immunosuppressive therapy strategies and patient outcomes after renal transplantation

Helio Tedesco-Silva, Claudia Rosso Felipe, Tainá Veras de Sandes Freitas, Marina Pontello Cristeli, Carolina Araújo Rodrigues, José Osmar Medina-Pestana

Transplant Research and Risk Management · 2011

DOI: 10.2147/trrm.s12217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Research and Risk Management, 2011. Verfasst von Helio Tedesco-Silva und 5 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Tedesco-Silva, H., Felipe, C. R., Freitas, T. V. D. S., Cristeli, M. P., Rodrigues, C. A., & Medina-Pestana, J. O. (2011). Impact of everolimus: update on immunosuppressive therapy strategies and patient outcomes after renal transplantation. Transplant Research and Risk Management. https://doi.org/10.2147/trrm.s12217

Vancouver

Tedesco-Silva H, Felipe CR, Freitas TVDS, Cristeli MP, Rodrigues CA, Medina-Pestana JO. Impact of everolimus: update on immunosuppressive therapy strategies and patient outcomes after renal transplantation. Transplant Research and Risk Management. 2011. doi:10.2147/trrm.s12217

BibTeX
@article{TedescoSilva2011,
  author = {Tedesco-Silva, Helio and Felipe, Claudia Rosso and Freitas, Tainá Veras de Sandes and Cristeli, Marina Pontello and Rodrigues, Carolina Araújo and Medina-Pestana, José Osmar},
  title = {Impact of everolimus: update on immunosuppressive therapy strategies and patient outcomes after renal transplantation},
  journal = {Transplant Research and Risk Management},
  year = {2011},
  doi = {10.2147/trrm.s12217}
}
Kostenlos starten →